| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/18/2014 | US20140271872 Drug delivery system |
| 09/18/2014 | US20140271871 Methods and compositions for treating pulmonary hypertension |
| 09/18/2014 | US20140271869 High drug load buprenorphine microspheres and method of producing same |
| 09/18/2014 | US20140271867 Film delivery system for active ingredients |
| 09/18/2014 | US20140271866 Transdermal drug delivery system containing rivastigmine |
| 09/18/2014 | US20140271865 Amphetamine transdermal compositions with acrylic block copolymer |
| 09/18/2014 | US20140271864 Therapeutic compositions for bone repair |
| 09/18/2014 | US20140271863 Hot washable poly-n-isopropylacrylamide hydrogel delivery systems |
| 09/18/2014 | US20140271862 Rapid Disperse Dosage Form Containing Levetiracetam |
| 09/18/2014 | US20140271859 Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability |
| 09/18/2014 | US20140271858 Coated tablets of eszopiclone |
| 09/18/2014 | US20140271857 Benzonatate modified release solid tablets and capsules |
| 09/18/2014 | US20140271856 Orally disintegrable tablets |
| 09/18/2014 | US20140271854 Opioid receptor modulator dosage formulations |
| 09/18/2014 | US20140271853 Novel formulations of proton pump inhibitors and methods of using these formulations |
| 09/18/2014 | US20140271852 Sustained release formulation of nalbuphine |
| 09/18/2014 | US20140271851 Antiemetic extended release solid dosage forms |
| 09/18/2014 | US20140271850 Controlled-Release Pharmaceutical Compositions Comprising Lamotrigine and Methods of Producing Same |
| 09/18/2014 | US20140271849 Abuse Deterrent Solid Dosage Form for Immediate Release with Functional Score |
| 09/18/2014 | US20140271848 Abuse-deterrent dosage forms |
| 09/18/2014 | US20140271847 Formulations and methods for rapid penile erections |
| 09/18/2014 | US20140271846 Gastroretentive dosage system and process of preparation thereof |
| 09/18/2014 | US20140271845 Coated substrate compositions |
| 09/18/2014 | US20140271844 Compositions containing nitro fatty acids |
| 09/18/2014 | US20140271842 Tofacitinib oral sustained release dosage forms |
| 09/18/2014 | US20140271841 Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
| 09/18/2014 | US20140271840 Controlled release hydrocodone formulations |
| 09/18/2014 | US20140271839 Extended-release topiramate capsules |
| 09/18/2014 | US20140271838 Pharmaceutical soft gelatin capsule dosage form with modified guar gum |
| 09/18/2014 | US20140271837 Pharmaceutical soft gelatin capsule dosage form |
| 09/18/2014 | US20140271835 Abuse resistant capsule |
| 09/18/2014 | US20140271834 Doxycycline Formulations, and Methods of Treating Rosacea |
| 09/18/2014 | US20140271832 Racecadotril lipid compositions |
| 09/18/2014 | US20140271831 Racecadotril liquid compositions |
| 09/18/2014 | US20140271830 Composition and method for gray hair treatment |
| 09/18/2014 | US20140271826 Kinetin/zeatin topical formulation |
| 09/18/2014 | US20140271825 Pharmaceutical formulations of chelating agents as a metal removal treatment system |
| 09/18/2014 | US20140271824 Acid Stable Liposomal Compositions And Methods For Producing The Same |
| 09/18/2014 | US20140271823 Inhibition of hypoxia-inducible factor activity with carica papaya extracts |
| 09/18/2014 | US20140271822 Modified docetaxel liposome formulations |
| 09/18/2014 | US20140271820 Liposome oxaliplatin compositions for cancer therapy |
| 09/18/2014 | US20140271819 Onapristone polymorphic forms and methods of use |
| 09/18/2014 | US20140271816 Treatment of potential platelet aggregation with liposomally formulated glutathione and clopidogrel |
| 09/18/2014 | US20140271814 Cell binding peptide drug delivery system and compound for treating cancer and tumors |
| 09/18/2014 | US20140271812 Treatment for chemotherapy-induced cognitive impairment |
| 09/18/2014 | US20140271801 Cardiovascular disease treatment and prevention |
| 09/18/2014 | US20140271799 Transdermal administration of fentanyl and analogs thereof |
| 09/18/2014 | US20140271796 Oxybutynin-containing transdermal absorption preparation |
| 09/18/2014 | US20140271795 Nanofibrous materials as drug, protein, or genetic release vehicles |
| 09/18/2014 | US20140271792 Methylphenidate transdermal compositions with rubber-based adhesives |
| 09/18/2014 | US20140271791 Oral energy products including encapsulated caffeine |
| 09/18/2014 | US20140271789 Sublingual and buccal film compositions |
| 09/18/2014 | US20140271788 Sublingual and buccal film compositions |
| 09/18/2014 | US20140271783 Prefabricated pharmaceutical dosage forms from functional polymer films |
| 09/18/2014 | US20140271780 Prostamide-containing intraocular implant |
| 09/18/2014 | US20140271772 Biodegradable subcutaneous implants and methods of making |
| 09/18/2014 | US20140271770 Methods And Compositions For Treating Post-Operative Pain Comprising Clonidine |
| 09/18/2014 | US20140271766 Methods and device for treating opioid addiction |
| 09/18/2014 | US20140271765 Methods and device for treating opioid addiction |
| 09/18/2014 | US20140271734 Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease |
| 09/18/2014 | US20140271733 Inhibition of central nervous system effects from smoking and sensory effects from smoking |
| 09/18/2014 | US20140271731 Cardiovascular disease treatment and prevention |
| 09/18/2014 | US20140271729 Use of biogenic amines spermine and spermidine for the homeopathic treatment of hormone imbalances |
| 09/18/2014 | US20140271727 Method of using an antidepressant for increasing immunity of a subject and treating cancer |
| 09/18/2014 | US20140271725 Small Molecule Enhancer for Dendritic Cell Cancer Vaccines |
| 09/18/2014 | US20140271716 Intra-testicular Injection of Immunogens |
| 09/18/2014 | US20140271706 Compositions and methods for utilization of algal compounds |
| 09/18/2014 | US20140271705 Nutraceutical compositions produced from co-products of corn or milo ethanol fermentation and methods of making and using thereof |
| 09/18/2014 | US20140271701 Use of mycobacterium avium paratuberculosis peptides to diagnose type 1 diabetes |
| 09/18/2014 | US20140271680 Methods and pharmaceutical compositions for treatment of pulmonary hypertension |
| 09/18/2014 | US20140271673 Use of lxr antagonists for treatment of side effects of elevated glucocorticoid levels |
| 09/18/2014 | US20140271670 Compositions for treating skin disorders |
| 09/18/2014 | US20140271668 Increasing parkin activity by administering a deubiquitinating enzyme inhibitor |
| 09/18/2014 | US20140271667 Methods and Compositions for Neoadjuvant Therapy |
| 09/18/2014 | US20140271665 Combinations of Kinase Inhibitors for the Treatment of Cancer |
| 09/18/2014 | US20140271662 Pyrazole derivatives as protein kinase modulators |
| 09/18/2014 | US20140271658 Anti-il-33 antibodies and uses thereof |
| 09/18/2014 | US20140271657 Combinatorial compositions and methods of treating hemoglobinopathies |
| 09/18/2014 | US20140271649 Methods and compositions for inhibiting staphylococcus agglutination in blood |
| 09/18/2014 | US20140271644 Combination/adjuvant therapy for wt-1-positive disease |
| 09/18/2014 | US20140271638 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas |
| 09/18/2014 | US20140271637 Methods of administering anti-tnfalpha antibodies |
| 09/18/2014 | US20140271634 Combinations of a mek inhibitor compound with an her3/egfr inhibitor compound and methods of use |
| 09/18/2014 | US20140271630 Rituximab induction therapy followed by glatiramer acetate therapy |
| 09/18/2014 | US20140271620 Modified hyaluronan and uses thereof in cancer treatment |
| 09/18/2014 | US20140271608 Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins |
| 09/18/2014 | US20140271606 Methods of using adenosine receptor antagonists for treating bleeding disorders |
| 09/18/2014 | US20140271605 Stable bioactive substances and methods of making |
| 09/18/2014 | US20140271604 HDAC Inhibitor Polymorphic Forms and Methods of Use |
| 09/18/2014 | US20140271595 Use of a combination of d-aspartic and l-aspartic acids or salts thereof for the treatment of male infertility |
| 09/18/2014 | US20140271594 Equine supplement |
| 09/18/2014 | US20140271593 Formulations of water-soluble derivatives of vitamin e and compositions containing same |
| 09/18/2014 | US20140271592 Treatment of Huntington's Disease |
| 09/18/2014 | US20140271591 Compositions and methods for the modulation of hemoglobin (s) |
| 09/18/2014 | US20140271573 Pharmaco-cellular therapeutic method for the treatment of muscular dystrophies |
| 09/18/2014 | US20140271568 Method and kit for providing an increased expression of telomerase, brain-derived neurotrophic factor, stromal cell-derived factor-1, cxc chemokine receptor 4, and/or immune regulatory factor of stem cell |
| 09/18/2014 | US20140271562 Composition for use in brain growth and/or cognitive and/or psychomotor development |
| 09/18/2014 | US20140271561 Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens |
| 09/18/2014 | US20140271558 Dietary Supplements Including Glucan and Fulvic Acid |
| 09/18/2014 | US20140271555 Activating adiponectin by casein hydrolysate |